Teunis Bernard H Geijtenbeek

Title: Teunis Bernard H Geijtenbeek: Innovator in Immune Modulation

Introduction

Teunis Bernard H Geijtenbeek is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of immunology, particularly in the modulation of immune responses. His work focuses on the interactions between dendritic cells and T-cells, which are crucial for understanding and manipulating immune responses in various medical contexts.

Latest Patents

Teunis Bernard H Geijtenbeek holds a patent for a composition and method for modulating dendritic cell-T cell interaction. The patent describes the use of a compound that binds to a C-type lectin on the surface of a dendritic cell. This invention aims to reduce the immune response in animals, particularly humans and other mammals. The composition can modulate interactions between dendritic cells and T-cells, which can be beneficial for preventing or inhibiting immune responses to specific antigens, inducing tolerance, and treating autoimmune diseases and allergies. The compounds used in this invention include mannose, fucose, plant lectins, antibiotics, sugars, proteins, or antibodies against C-type lectins.

Career Highlights

Teunis Bernard H Geijtenbeek is affiliated with Katholieke Universiteit Nijmegen, where he conducts research and develops innovative solutions in immunology. His work has led to advancements in understanding immune modulation, which has implications for various therapeutic applications.

Collaborations

Teunis has collaborated with notable researchers in his field, including Carl Gustav Figdor and Yvette Van Kooyk. These collaborations have contributed to the depth and impact of his research in immune modulation.

Conclusion

Teunis Bernard H Geijtenbeek is a prominent inventor whose work in immune modulation has the potential to influence therapeutic strategies for autoimmune diseases and allergies. His innovative approaches continue to advance the field of immunology.